These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Immunofluorescent studies of the serologic reactivity of patients with malignant melanoma against tumor-associated cytoplasmic antigens. Wood GW; Barth RF J Natl Cancer Inst; 1974 Aug; 53(2):309-16. PubMed ID: 4602060 [No Abstract] [Full Text] [Related]
4. Immunofluorescent detection of common melanoma membrane antigens by sera of melanoma patients immunized against autologous or allogeneic cultured melanoma cells. Leong SP; Sutherland CM; Krementz ET Cancer Res; 1977 Nov; 37(11):4035-42. PubMed ID: 332343 [No Abstract] [Full Text] [Related]
5. Epidermal cytoplasmic antibodies: incidence and type in normal persons and patients with melanoma. Abel EA; Bystryn JC J Invest Dermatol; 1976 Jan; 66(1):44-8. PubMed ID: 1107434 [TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical analysis of antimelanoma monoclonal antibodies, with special reference to fetal tissue distribution. Kageshita T; Johno M; Ono T; Arao T; Imai K J Invest Dermatol; 1985 Dec; 85(6):535-7. PubMed ID: 3905976 [TBL] [Abstract][Full Text] [Related]
7. Effect of different fixatives on the localization of human melanoma antigens by immunofluorescence. Leong SP; Cooperband SR; Deckers PJ; Sutherland CM; Cesare JF; Krementz ET Oncology; 1979; 36(5):202-7. PubMed ID: 384307 [TBL] [Abstract][Full Text] [Related]
9. Antibodies and antigen expression in human melanoma detected by the immune adherence test. Cornain S; de Vries JE; Collard J; Vennegoor C; van Wingerden I; Rümke P Int J Cancer; 1975 Dec; 16(6):981-97. PubMed ID: 1104492 [TBL] [Abstract][Full Text] [Related]
15. Antigens and antibodies in malignant melanoma. Merimsky O; Shoenfeld Y; Chaitchik S; Yecheskel G; Fishman P Tumour Biol; 1994; 15(4):188-202. PubMed ID: 7939169 [TBL] [Abstract][Full Text] [Related]
16. Identification of immunogenic human melanoma antigens in a polyvalent melanoma vaccine. Bystryn JC; Henn M; Li J; Shroba S Cancer Res; 1992 Nov; 52(21):5948-53. PubMed ID: 1382848 [TBL] [Abstract][Full Text] [Related]
17. Immunological studies in patients with malignant melanoma of the uvea. Brownstein S; Sheikh KM; Lewis MG Can J Ophthalmol; 1977 Jan; 12(1):16-23. PubMed ID: 849536 [TBL] [Abstract][Full Text] [Related]
18. Detection of human malignant melanoma antigens by immunofluorescence and autologous postimmune antimelanoma sera. Leong SP Ann N Y Acad Sci; 1983; 420():237-50. PubMed ID: 6372592 [TBL] [Abstract][Full Text] [Related]
19. Membrane associated antigens of human malignant melanoma. III. Specificity of human sera reacting with cultured melanoma cells. Seibert E; Sorg C; Happle R; Macher E Int J Cancer; 1977 Feb; 19(2):172-8. PubMed ID: 402317 [TBL] [Abstract][Full Text] [Related]
20. Absence of melanoma specificity in the reactivity of melanoma patients' sera with cultured allogeneic melanoma cell lines. Dent PB; Liao SK; McCulloch PB; Stone BR; Singal DP Cancer; 1982 May; 49(10):2043-8. PubMed ID: 6176308 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]